Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function

Completed · Not applicable · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of the present study is to determine if use of dietary supplement tauroursodeoxycholic acid enhances insulin-stimulated leg blood flow and glucose disposal.

Key facts

Study ID

NCT03331432

Run by

University of Missouri-Columbia

People needed

8

Starts

2015-10-28

Expected to finish

2018-02-14

Last updated by the study team

2018-02-19

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes diagnosed by primary physician
• Body mass index less then 43 kg/m2

You may not qualify if…

• Recent weight gain or loss (>5% body weight in the last 3 months)
• Pregnancy
• Consumption of >14 alcoholic beverages per week
• Changes in the medication use or dose within the last 3 months
• Known cardiovascular or pulmonary disease
• Taking medication for advanced retinopathy or neuropathy
• Taking prescription anticoagulants
• Nicotine use

Where it is running

• University of Missouri — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.